Kestra Medical Technologies, Ltd. Stock Analysis & AI Score
Kestra Medical Technologies, Ltd. (KMTS) has an ST Score of 30.8 (C-), driven by its Valuation (B-) and held back by its Sentiment (F). Analysts rate it Buy with a $30.67 price target (+19.1% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Kestra Medical Technologies, Ltd. (KMTS) has an ST Score of 30.8 (C-), driven by its Valuation (B-) and held back by its Sentiment (F). Analysts rate it Buy with a $30.67 price target (+19.1% upside).
- Strongest
- ValuationB-
- Weakest
- SentimentF
All factor grades
- ValuationB-
- Financial StrengthB-
- MomentumB-
- ForecastB-
- ProfitabilityD-
- GrowthF
- SentimentF
- Piotroski2/9
Contact
KMTS stock: frequently asked questions
What is KMTS's ST Score?
Kestra Medical Technologies, Ltd. (KMTS) has an ST Score of 30.8 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is KMTS a buy, hold, or sell?
Analysts rate KMTS a Buy, with a price target of $30.67 (+19.1% vs the current price). Our ST Score grades it C- (30.8/100). The ST Score is a data-driven signal, not a recommendation.
What are KMTS's factor grades?
Valuation B-, Profitability D-, Financial Strength B-, Momentum B-, Growth F, Forecast B-, Sentiment F.
What is KMTS's valuation grade?
Kestra Medical Technologies, Ltd. (KMTS) earns a valuation grade of B-, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is KMTS's growth grade?
Kestra Medical Technologies, Ltd. (KMTS) earns a growth grade of F, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is KMTS's profitability grade?
Kestra Medical Technologies, Ltd. (KMTS) earns a profitability grade of D-, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is KMTS's financial strength grade?
Kestra Medical Technologies, Ltd. (KMTS) earns a financial strength grade of B-, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for KMTS?
The average analyst price target for Kestra Medical Technologies, Ltd. (KMTS) is $30.67 from 4 analysts, which is +19.1% versus the recent price of $25.76.
What is KMTS's Piotroski score?
Kestra Medical Technologies, Ltd. (KMTS) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.